OrbiMed Advisors LLC's Form 4 filing
Verona Pharma plc (VRNA) · filed Dec 27, 2022
- Accession no.
- 0000947871-22-001257
- Filed
- Dec 27, 2022, 5:38 PM ET
- Trade date
- Dec 22-23, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $136.0M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital GP VI LLCCIK 0001682115 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 | Ordinary Shares | SSaleDisposed | −3,284,800 | $21.71F2 | −$71,313,008 | 36,940,592 | Indirect | Duplicate filing |
| Dec 22, 2022 | Ordinary Shares | SSaleDisposed | −684,696 | $22.07F3 | −$15,111,240.72 | 36,255,896 | Indirect | Duplicate filing |
| Dec 23, 2022 | Ordinary Shares | SSaleDisposed | −961,328 | $22.27F4 | −$21,408,774.56 | 35,294,568 | Indirect | Duplicate filing |
| Dec 23, 2022 | Ordinary Shares | SSaleDisposed | −1,116,048 | $23.23F5 | −$25,925,795.04 | 34,178,520 | Indirect | Duplicate filing |
| Dec 23, 2022 | Ordinary Shares | SSaleDisposed | −92,992 | $24.11F6 | −$2,242,037.12 | 34,085,528 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price of the Ordinary Shares sold, ranging from a low of $21.00 to a high of $21.99 per Ordinary Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Ordinary Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price of the Ordinary Shares sold, ranging from a low of $22.00 to a high of $22.26 per Ordinary Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Ordinary Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of the Ordinary Shares sold, ranging from a low of $21.89 to a high of $22.87 per Ordinary Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Ordinary Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of the Ordinary Shares sold, ranging from a low of $22.89 to a high of $23.88 per Ordinary Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Ordinary Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price of the Ordinary Shares sold, ranging from a low of $23.90 to a high of $24.35 per Ordinary Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Ordinary Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.